Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2001
07/04/2001CN1302184A Composition for keeping away vermin
07/04/2001CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them
07/04/2001CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists
07/04/2001CN1068000C Apolioprotein -B synthesis inhibitors
07/04/2001CN1067994C Bistesorcinyltriazines
07/04/2001CN1067847C Microbicides
07/03/2001US6255484 Cyanurate compound having three oxetane ring groups and organic hardening compositions containing same
07/03/2001US6255483 Biphenyl-substituted triazines
07/03/2001US6255342 Pesticides
07/03/2001US6255336 Amino ceramide-like compounds and therapeutic methods of use
07/03/2001US6255323 Anticancer agents
07/03/2001US6255301 Amino acid derivatives and their use as thrombin inhibitors
07/03/2001US6254724 Stabilizing amount of a hindered amine compound selected derivatives of 1-oxyl-2,2,6,6-tetramethyl-piperidin-4-ol or which are their hydroxylamine salts
07/03/2001CA2006222C Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
06/2001
06/28/2001WO2001046451A1 Migrastatin, process for producing the same and medicinal compositions
06/28/2001WO2001046263A1 Novel compounds
06/28/2001WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
06/28/2001WO2001046178A2 Substituierte bisindolymaleimide
06/28/2001WO2001046177A1 Benzofuran derivatives
06/28/2001WO2001046176A2 Non peptide tachykinin receptor antagonists
06/28/2001WO2001046175A1 Diamidine compounds as dna minor groove binders
06/28/2001WO2001046174A1 Novel compounds
06/28/2001WO2001046151A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/28/2001WO2001046150A2 Quinolone compounds for use in treating viral infections
06/28/2001WO2001046148A1 Novel processes
06/28/2001WO2001046145A1 New modulators of dopamine neurotransmission
06/28/2001WO2001046144A1 New modulators of dopamine neurotransmission
06/28/2001WO2001045700A1 Urotensin-ii receptor antagonists
06/28/2001WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
06/28/2001WO2001010834A3 Antibacterial agents
06/28/2001WO2001009122A3 Serotonergic benzofurans
06/28/2001WO2001002355A3 Indole synthesis
06/28/2001WO2000071171A3 Sigma-1 ligands for determining carcinoma proliferative status
06/28/2001WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis
06/28/2001CA2399584A1 Non peptide tachykinin receptor antagonists
06/28/2001CA2395300A1 Novel compounds
06/28/2001CA2394864A1 Novel compounds
06/28/2001CA2394852A1 Substituted pyrroles
06/28/2001CA2392150A1 Diamidine compounds as dna minor groove binders
06/27/2001EP1110961A1 Oxygenic heterocyclic compounds
06/27/2001EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
06/27/2001EP1110952A1 Carboxylic acid derivates, their preparation and use
06/27/2001EP1110951A1 Pyrimidine derivatives
06/27/2001EP1109806A1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
06/27/2001EP1109804A1 Chemokine receptor antagonists and methods of use therefor
06/27/2001EP1109800A1 Novel cdk inhibitors having flavone structure
06/27/2001EP1109799A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
06/27/2001EP1109790A1 1, 2, 4-triazole-3-thione compounds
06/27/2001EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
06/27/2001EP1109619A1 Reactor comprising a contact tube bundle
06/27/2001EP1109580A1 Methods for treating or preventing viral infections and associated diseases
06/27/2001EP1109554A2 Pipecolic acid derivatives for vision and memory disorders
06/27/2001EP1109551A1 4-amino-3-mercapto-1,2,4-triazoles
06/27/2001EP1109544A1 Potassium channel inhibitors and method
06/27/2001EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
06/27/2001EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
06/27/2001EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides
06/27/2001CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
06/27/2001CN1301154A Amide derivatives and nociceptin antagonists
06/26/2001US6252094 Using onium salt in aqueous solvent
06/26/2001US6252086 4-alkenyl-and 4-alkynyloxindoles
06/26/2001US6252082 Cardiovascualr disorders
06/26/2001US6252080 Herpes, cytomegalo virus
06/26/2001US6252072 Hydrolysis of the corresponding triazine compound
06/26/2001US6251919 Administering aniline derivative for therapy of pain
06/26/2001US6251914 Treating cytokine mediated diseases
06/26/2001US6251908 Piperazine derivatives
06/26/2001US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics
06/26/2001US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
06/26/2001US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives
06/26/2001US6251830 Pesticides and herbicides
06/24/2001CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
06/21/2001WO2001044225A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
06/21/2001WO2001044223A1 Inhibitors of interleukin 5 gene expression
06/21/2001WO2001044208A1 4,6-substituted 2-amino-1,3,5-triazine derivatives, a method for producing same and the use thereof as herbicides and plant growth regulators
06/21/2001WO2001044207A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
06/21/2001WO2001044202A1 Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same
06/21/2001WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists
06/21/2001WO2001044200A2 Selective neurokinin antagonists
06/21/2001WO2001044191A1 4-aminopiperidine derivatives and their use as medicine
06/21/2001WO2001044180A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
06/21/2001WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation
06/21/2001WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation
06/21/2001WO2001029245A3 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS
06/21/2001US20010004629 Improved toleration by crops, insecticidal and/or spectrum of action
06/21/2001CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation
06/21/2001CA2393672A1 Selective neurokinin antagonists
06/21/2001CA2393027A1 Inhibitors of interleukin 5 gene expression
06/21/2001CA2388226A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
06/20/2001EP1109070A2 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers
06/20/2001EP1107964A1 Isoquinoline derivatives with angiogenesis inhibiting activity
06/20/2001EP1107956A2 Use of 5-amino-pyrazol-derivatives for combating micro-organisms
06/20/2001EP1107760A2 4-quinolinemethanol derivatives as purine receptor antagonists (i)
06/20/2001EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
06/20/2001EP1107752A1 Pyrrolidine derivatives for vision and memory disorders
06/20/2001EP0984961B1 Novel pyridine derivatives and pharmaceutical compositions containing them
06/20/2001EP0890176B1 Proton conductor in liquid form
06/20/2001EP0808303B1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist